drugset / Trial / NCT00048204

A Study Of A New Medicine (GW597599B) For The Treatment Of Major Depressive Disorder

NCT00048204

Phase 2 Completed 372 enrolled GlaxoSmithKline
RandomizedParallel-groupDouble-blindTreatment

Summary

A Placebo Controlled Study Evaluating Efficacy And Safety of Medication In Patients With Major Depressive Disorder (MDD)

Timeline

Start
2002-11-04
Primary completion
2003-09-30
Completion
2003-09-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Paroxetine Small molecule
Subject Vestipitant Small molecule